Nonalcoholic Steatohepatitis Completed Phase 2 Trials for Pentoxifylline (DB00806)

Also known as: Non-Alcoholic Steato-Hepatitis / Non Alcoholic Steato Hepatitis / Steatohepatitis, Nonalcoholic / Non-Alcoholic Steatohepatitis / Non Alcoholic Steatohepatitis / Nonalcoholic steatohepatitis (disorder) / Nonalcoholic steatohepatitis (NASH)

IndicationStatusPhase
DBCOND0029353 (Nonalcoholic Steatohepatitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00590161Pentoxifylline in Patients With Nonalcoholic SteatohepatitisTreatment